MICHAEL W ROGERS Insider Trading $KERX KERYX BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for MICHAEL W ROGERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
MICHAEL W ROGERS in KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W ROGERS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W ROGERS in KERYX BIOPHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | D | 0.00 | 140,000 | 0 | 0 | |
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Sell | D | 0.00 | 30,000 | 0 | 0 | 30 K to 0 (-100.00 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | A | 5.71 | 30,000 | 171,300 | 30,000 | |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1